Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions.
D007516:Adenoma, Islet Cell / Q000150:complications / Q000175:diagnosis*; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000150:complications; D002648:Child; D003937:Diagnosis, Differential; D000431:Ethanol / Q000009:adverse effects; D005260:Female; D005934:Glucagon / Q000008:administration & dosage; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood*; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000150:complications / Q000175:diagnosis*; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000009:adverse effects
D001786:Blood Glucose; D007328:Insulin; D000431:Ethanol; D005934:Glucagon; D014044:Tolbutamide